PFE - Pfizer Inc.
Close
29.01
0.290 1.000%
Share volume: 37,110,584
Last Updated: Fri 30 Aug 2024 10:02:13 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$28.72
0.29
1.01%
View ratios
Fiscal Date | 2022-07-03 | 2022-10-02 | 2022-12-31 | 2023-04-02 | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-10 | 2022-11-09 | 2023-02-23 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-02-22 | 2024-05-08 | |
Total revenue | 27.742 B | 22.638 B | 24.289 B | 18.282 B | 12.734 B | 13.232 B | 14.248 B | 14.878 B | |
Cost of revenue | 8.648 B | 6.063 B | 9.649 B | 4.886 B | 3.237 B | 9.269 B | 7.562 B | 3.379 B | |
Gross profit | 19.094 B | 16.575 B | 14.640 B | 13.396 B | 9.497 B | 3.963 B | 6.686 B | 11.499 B | |
-13.19% | -11.67% | -8.50% | -29.11% | -58.27% | 68.71% | 71.99% | |||
Operating expenses | 5.863 B | 6.087 B | 8.261 B | 5.923 B | 6.145 B | 5.992 B | 7.390 B | 5.988 B | |
Selling general and admin | 3.048 B | 3.391 B | 4.645 B | 3.418 B | 3.497 B | 3.281 B | 4.575 B | 3.495 B | |
Research and development | 2.815 B | 2.696 B | 3.616 B | 2.505 B | 2.648 B | 2.711 B | 2.815 B | 2.493 B | |
Total expenses | 15.333 B | 13.023 B | 18.989 B | 11.912 B | 10.566 B | 16.440 B | 16.219 B | 10.675 B | |
-15.07% | 45.81% | -37.27% | -11.30% | 55.59% | -1.34% | -34.18% | |||
Operating income | 12.409 B | 9.615 B | 5.300 B | 6.370 B | 2.168 B | -3.208 B | -1.971 B | 4.203 B | |
Ebit | 12.780 B | 9.858 B | 5.789 B | 6.710 B | 2.604 B | -2.807 B | -1.431 B | 4.115 B | |
Pretax income | 11.446 B | 9.002 B | 5.229 B | 6.272 B | 2.268 B | -3.350 B | -4.132 B | 3.421 B | |
-21.35% | -41.91% | 19.95% | -63.84% | -247.71% | 23.34% | -182.79% | |||
Income tax | 1.570 B | 356.000 M | 230.000 M | 715.000 M | -71.000 M | -964.000 M | -794.000 M | 293.000 M | |
Net income basic | 9.906 B | 8.608 B | 4.995 B | 5.543 B | 2.327 B | -2.382 B | -3.370 B | 3.115 B | |
-13.10% | -41.97% | 10.97% | -58.02% | -202.36% | -41.48% | 192.43% | |||
Net income | 9.906 B | 8.608 B | 4.995 B | 5.543 B | 2.327 B | -2.382 B | -3.370 B | 3.115 B | |
-13.10% | -41.97% | 10.97% | -58.02% | -202.36% | -41.48% | 192.43% |